Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00310323 · ClinicalTrials.gov registry record · NA
Hepatic Drug Biotransformation in Children With Obstructive Sleep Apnea
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 69
- Enrollment target
NCT00310323 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 69 participants.
The verdict
NCT00310323, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 69 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine the effect of chronic nighttime low oxygen saturations on selected body systems (liver) that break down drugs in children with obstructive sleep apnea syndrome (OSAS).
Interventions
- DRUG Caffeine
- DRUG Dextromethorphan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2003-01 |
| Est. Completion | 2006-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00310323
The ClinicalTrials.gov registry entry for NCT00310323 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Caffeine is the first listed.
NCT00310323 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00310323 about?
NCT00310323 is a clinical study titled "Hepatic Drug Biotransformation in Children With Obstructive Sleep Apnea". The purpose of this research study is to determine the effect of chronic nighttime low oxygen saturations on selected body systems (liver) that break down drugs in children with obstructive sleep apnea syndrome (OSAS).
What is the current status of trial NCT00310323?
This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2003-01. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00310323?
The interventions under investigation include: Caffeine (DRUG), Dextromethorphan (DRUG).
Who is sponsoring clinical trial NCT00310323?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.